Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics
08/12/2025 13:58
Dec 8 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S: MIRUM PHARMACEUTICALS TO ACQUIRE HBM PORTFOLIO COMPANY BLUEJAY THERAPEUTICS FOR UP TO USD 820 MLN MIRUM TO PAY USD 250 MLN CASH AND USD 370 MLN IN STOCK POTENTIAL MILESTONE PAYMENTS UP TO USD 200 MLN IN CASH HBM TO RECEIVE USD 6 MLN CASH AND USD 7 MLN IN SHARES ADDITIONAL PAYMENTS UP TO USD 3.7 MLN UPON MILESTONES Source text: ID:nEQ4XxTjfa Further company coverage: HBMN.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX